Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at ...

Joule for Consultants isn’t only reducing repetitive work; it’s also reshaping how KPMG approaches SAP-enabled ...

Brex reports that recurring revenue, a predictable income stream, is key for modern business growth and stability, ...

Potential deregulation is a further complicating factor. In November 2025, the FCC voted 2-1 to rescind a January 2025 ruling ...

There is no single technology that will power the AI era; rather, I expect that the future lies in a portfolio of firm, ...

D: 8 p.m. ETThe House Ways and Means Committee hearing has concluded, bringing a long day of questioning for major health ...

2-Year U.S. Treasury Note Continuous Contract $104.141 0.020 0.02% 5-Year U.S. Treasury Note Continuous Contract $108.711-0.016-0.01% 10-Year U.S. Treasury Note Continuous Contract $111.609-0.141-0.13 ...

2-Year U.S. Treasury Note Continuous Contract $104.137-0.047-0.04% 5-Year U.S. Treasury Note Continuous Contract $108.844-0.164-0.15% 10-Year U.S. Treasury Note Continuous Contract $112.000-0.219-0.19 ...

As workplace risks grow more complex, industrial hygiene programs must align exposure assessment strategies with analytical excellence to deliver meaningful worker protection.

Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.